Cullinan Therapeutics, Inc. Earnings Per Share Diluted

Quick Answer

Cullinan Therapeutics, Inc. reported Earnings Per Share Diluted of $3.69 (loss) per share for the year ending 2023.

  • Cullinan Therapeutics, Inc. showed a decrease of -255.0% in Earnings Per Share Diluted from 2022 to 2023.
  • This data is from Cullinan Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 14, 2024.
  • XBRL data for this metric is available from 2021 to 2023 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2021 to 2023), Cullinan Therapeutics, Inc.'s Earnings Per Share Diluted has declined by 142.8%.
  • Historical annual values: Fiscal year 2023: $3.69 (loss) per share | Fiscal year 2022: $2.38 per share | Fiscal year 2021: $1.52 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: